Lin Yan1, Huasong Yu1, Xiaoyi Xu2

  • 1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.

Frontiers in oncology
|October 30, 2025
PubMed
概括

这项研究确定了急性髓性白血病 (AML) 中的关键基因,以预测患者的结果. 一种新的预后模型,MLAPS,显示出强大的预测能力,CD69是AML的潜在治疗目标.